Holtec Nuclear Corporation has filed for an initial public offering and plans to list on Nasdaq under the ticker HNUC. The move gives the nuclear supplier and reactor developer a public-market path to fund its next phase, including work on SMRs and manufacturing expansion.
The timing matters because Holtec is not a pre-commercial start-up chasing a first product. Founded in 1986, it already supplies nuclear equipment, manages spent nuclear fuel and posted $165 million of revenue and $17.8 million of net income in the first three months of this year, down from $177.7 million and $25.4 million a year earlier. That makes the IPO a growth bid from an operating business, not a bet on a concept.
Holtec’s plans also give investors a new way to approach the nuclear trade at a moment when interest in the sector is being split between operating companies and early-stage developers. The company is leading the restart of the 800-megawatt Palisades nuclear plant in Michigan, which shut down in 2022 after 50 years of operation, and it plans to build two SMR-300s there. It also has a second site in view: the decommissioned Oyster Creek nuclear power plant in New Jersey, where it plans four SMR-300s.
The financing picture is not spotless. Holtec has already received $400 million from the U.S. Department of Energy for its development plans at Palisades, and it wants IPO proceeds to push its SMR program, expand manufacturing capacity and support other growth initiatives. But it is going to the public markets while recent operating results have softened, which makes the filing as much a test of investor patience as of nuclear enthusiasm.
That contrast is sharper when set beside Oklo, the early-stage nuclear developer that has no commercial power revenue yet and may not book its first before 2028. Holtec has revenue, profit and an existing industrial base. The question now is how much public-market value investors will assign to that mix — and what valuation the company will target when it prices the offering.
